Table 3B.
Pre-transplant HLA and non-HLA antibodies: comparison between ABMRhDSApos and non-ABMRhDSApos cases (normal histology, IFTA and ABMRhDSAneg cases).
| ABMRhDSApos (n = 38)* | No ABMRhDSApos (n = 80)* | p-value | |
|---|---|---|---|
| Pre-transplant HLA-DSA (yes, %) | 17 (53.1) | 12 (17.4) | <0.001 |
| Pre-transplant AT1R-Ab (yes, %) | 16 (50) | 7 (10.1) | <0.001 |
| Pre-transplant ETAR-Ab (yes, %) | 10 (31.2) | 14 (20.3) | 0.23 |
| Pre-transplant MICA-Ab (yes, %) | 3 (9.4) | 6 (8.7) | 1.00 |
| Pre-transplant EC-XM (positive, %)$ | 1 (4.5) | 5 (8.2) | 1.00 |
*32 ABMRhDSApos cases and 69 non-ABMRhDSApos cases with pre-transplant available samples. $22 ABMRhDSApos and 61 non-ABMRhDSApos cases.